Avedro, Inc.

AVDR

US05355N1090

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		+0.61%	-.--%

2019	Avedro, Inc.(NasdaqGM:AVDR) dropped from S&P TMI Index	CI
2019	Avedro, Inc. Announces Board Changes	CI

Avedro, Inc. Appoints Robert J. Palmisano to its Board of Directors

May 14, 2014 at 09:31 am IST

Avedro, Inc. announced that Robert J. Palmisano is joining its Board of Directors. Mr. Palmisano is the current President & CEO of Wright Medical Group, Inc.

Latest news about Avedro, Inc.

Avedro, Inc.(NasdaqGM:AVDR) dropped from S&P TMI Index	22/19/22	CI
Avedro, Inc. Announces Board Changes	21/19/21	CI
Avedro, Inc.(NasdaqGM:AVDR) dropped from NASDAQ Composite Index	21/19/21	CI
Glaukos Corporation completed the acquisition of Avedro, Inc. from a group of sellers.	21/19/21	CI
Avedro, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	06/19/06	CI
Certain Common Stock of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.	13/19/13	CI
Certain Options of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.	13/19/13	CI
Certain Warrants of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.	13/19/13	CI
Certain Restricted Stock Units of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.	13/19/13	CI
Avedro, Inc. Announces Resignation of Thomas W. Burns and Gilbert H. Kliman from the Board of Directors	08/19/08	CI
Avedro, Inc. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2019; Revises Revenue Guidance for the Full Year of Fiscal 2019	08/19/08	CI
Glaukos Corporation entered into a definitive merger agreement to acquire Avedro, Inc. from a group of sellers for approximately $490 million.	07/19/07	CI
Avedro, Inc.(NasdaqGM:AVDR) added to Russell 2000 Dynamic Index	28/19/28	CI
Avedro, Inc.(NasdaqGM:AVDR) added to S&P TMI Index	24/19/24	CI
Transcript : Avedro, Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-14-2019 05:15 PM	15/19/15
Transcript : Avedro, Inc., Q1 2019 Earnings Call, May 09, 2019	10/19/10
Avedro, Inc. Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2019; Revises Revenue Guidance for the Full Year of Fiscal 2019	10/19/10	CI
Transcript : Avedro, Inc., Q4 2018 Earnings Call, Mar 21, 2019	22/19/22
Avedro, Inc. Announces Unaudited Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2018; Provides Revenue Guidance for the Full Year of 2019	22/19/22	CI
Avedro, Inc.(NasdaqGM:AVDR) added to NASDAQ Composite Index	15/19/15	CI
Avedro, Inc. has completed an IPO in the amount of $70 million.	13/19/13	CI
Avedro, Inc. has filed an IPO in the amount of $86.25 million.	18/19/18	CI
Avedro To Seek Acquisition	18/19/18	CI
Avedro, Inc. Auditor Raises 'Going Concern' Doubt	21/18/21	CI
Avedro, Inc. Announces That Permanent J Code Issued for Avedro’S Photrexa® Drug Formulations	20/18/20	CI

Avedro Inc is a United States-based company. The Company is an ophthalmic pharmaceutical and medical device company developing and commercializing a suite of products based on its corneal collagen cross-linking technology platform to address a wide variety of ophthalmic disorders and conditions, primarily associated with corneal weakness. Its primary components of the Avedro Cross-Linking Platform are pharmaceutical formulations of riboflavin (vitamin B2), a âsingle dose pharmaceutical,â sold primarily in conjunction with the Companyâs innovative devices for the delivery of metered doses of ultraviolet (UVA) light, a medical device.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
AVEDRO, INC.	-.--%	403M
ABBOTT LABORATORIES	-7.16%	178B
MEDTRONIC PLC	-1.23%	107B
BECTON, DICKINSON AND COMPANY	-4.86%	67.04B
DEXCOM, INC.	-4.28%	47.23B
CENCORA, INC.	+10.32%	44.62B
HOYA CORPORATION	+8.14%	42.5B
METTLER-TOLEDO INTERNATIONAL, INC.	+15.76%	29.99B
TERUMO CORPORATION	+15.53%	25.22B
WEST PHARMACEUTICAL SERVICES, INC.	-5.88%	24.14B

Other Medical Equipment, Supplies & Distribution

Avedro, Inc.

Equities

AVDR

US05355N1090

Medical Equipment, Supplies & Distribution

Avedro, Inc. Appoints Robert J. Palmisano to its Board of Directors

Latest news about Avedro, Inc.

Chart Avedro, Inc.

Company Profile

Sector Other Medical Equipment, Supplies & Distribution